Greenwich LifeSciences, Inc.
GLSI
$16.80
$0.422.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 184.04% | 282.01% | 50.98% | -34.61% | -56.75% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 184.04% | 282.01% | 50.98% | -34.61% | -56.75% |
|
|
|||||
| Total Current Assets | 184.04% | 282.01% | 50.98% | -34.61% | -56.75% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 184.04% | 281.90% | 50.91% | -34.64% | -56.77% |
|
|
|||||
| Total Accounts Payable | 346.98% | 418.52% | 80.23% | 60.32% | -3.48% |
| Total Accrued Expenses | 56.02% | 54.87% | 94.23% | 154.42% | 155.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 241.68% | 263.93% | 82.88% | 92.55% | 24.58% |
|
|
|||||
| Total Current Liabilities | 241.68% | 263.93% | 82.88% | 92.55% | 24.58% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 241.68% | 263.93% | 82.88% | 92.55% | 24.58% |
|
|
|||||
| Common Stock & APIC | 33.37% | 38.66% | 27.37% | 26.43% | 22.11% |
| Retained Earnings | -31.74% | -33.69% | -28.56% | -33.51% | -32.45% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 116.53% | 301.60% | -61.13% | -56.15% | -75.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 116.53% | 301.60% | -61.13% | -56.15% | -75.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 116.53% | 301.60% | -61.13% | -56.15% | -75.50% |
|
|
|||||